NetTargets Inc.
09 Jun 2021
NetTargets has partnered with Cellkey, which provides a cutting-edge AI-based glycopeptide analysis platform, to discover biomarkers for early detection and treatment of cancer.
NetTargets will deliver a virtual presentation at Biotech Showcase™ 2023, to be held on 09-11 January (Presentation Schedule : January 09 2023, 2:00 PM(PST)). It will also participate in the virtual partnering meeting on 18-19 January 2023.